Product
Nasal Diazepam
1 clinical trial
2 indications
Indication
EpilepsyIndication
PartialClinical trial
Exploratory Open-Label Study of Effects on Responsive Neurostimulator Activity After Intranasal Administration of Single Dose of Valtoco® to People With EpilepsyStatus: Completed, Estimated PCD: 2022-11-10